Bone turnover in pregnancy, measured by urinary CTX, is influenced by vitamin D supplementation and is associated with maternal bone health: findings from the Maternal Vitamin D Osteoporosis Study (MAVIDOS) trial
暂无分享,去创建一个
A. Prentice | H. Inskip | K. Godfrey | A. Papageorghiou | R. Eastell | N. Arden | K. Maslin | E. Dennison | M. Javaid | N. Harvey | S. Kennedy | S. D'Angelo | R. Fraser | S. Crozier | M. Mughal | R. Moon | M. Clynes | E. Curtis | C. Cooper | F. Gossiel | N. Bishop | C. Parsons | S. Gandhi | I. Schoenmakers | S. Woolford | A. Carr | S. D’Angelo
[1] A. Prentice,et al. Pregnancy‐Related Change in pQCT and Bone Biochemistry in a Population With a Habitually Low Calcium Intake , 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[2] T. Sairenchi,et al. Changes in vitamin D status considering hemodilution factors in Japanese pregnant women according to trimester: A longitudinal survey , 2020, PloS one.
[3] A. Prentice,et al. Pregnancy‐Related Bone Mineral and Microarchitecture Changes in Women Aged 30 to 45 Years , 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[4] C. Cooper,et al. Gestational Vitamin D Supplementation Leads to Reduced Perinatal RXRA DNA Methylation: Results From the MAVIDOS Trial , 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[5] E. Nahas,et al. Effect of isolated vitamin D supplementation on bone turnover markers in younger postmenopausal women: a randomized, double-blind, placebo-controlled trial , 2018, Osteoporosis International.
[6] R. Segurado,et al. Calcium intake in winter pregnancy attenuates impact of vitamin D inadequacy on urine NTX, a marker of bone resorption , 2018, European Journal of Nutrition.
[7] R. Eastell,et al. Use of bone turnover markers in postmenopausal osteoporosis. , 2017, The lancet. Diabetes & endocrinology.
[8] W. Kang,et al. Effect of parity on bone mineral density: A systematic review and meta-analysis. , 2017, Bone.
[9] C. Kovacs. The Skeleton Is a Storehouse of Mineral That Is Plundered During Lactation and (Fully?) Replenished Afterwards , 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[10] M. Caudill,et al. Maternal vitamin D biomarkers are associated with maternal and fetal bone turnover among pregnant women consuming controlled amounts of vitamin D, calcium, and phosphorus. , 2017, Bone.
[11] T. Harris,et al. Association of bone turnover markers with volumetric bone loss, periosteal apposition, and fracture risk in older men and women: the AGES-Reykjavik longitudinal study , 2016, Osteoporosis International.
[12] C. Cooper,et al. Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial. , 2016, The lancet. Diabetes & endocrinology.
[13] J. Heinrich,et al. Associations between serum 25-hydroxyvitamin D and bone turnover markers in a population based sample of German children , 2015, Scientific Reports.
[14] R. Chapurlat,et al. Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? , 2015, The Journal of clinical endocrinology and metabolism.
[15] M. Brekke,et al. Effect of vitamin D3-supplementation on bone markers (serum P1NP and CTX): A randomized, double blinded, placebo controlled trial among healthy immigrants living in Norway , 2015, Bone reports.
[16] J. Tarín,et al. Bone metabolic changes during pregnancy: a period of vulnerability to osteoporosis and fracture. , 2014, European journal of endocrinology.
[17] R. Eastell,et al. Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study , 2015, Osteoporosis International.
[18] K. Kordas,et al. Effect of calcium supplementation on bone resorption in pregnancy and the early postpartum: a randomized controlled trial in Mexican Women , 2014, Nutrition Journal.
[19] A. Prentice,et al. 25(OH)D2 Half-Life Is Shorter Than 25(OH)D3 Half-Life and Is Influenced by DBP Concentration and Genotype , 2014, The Journal of clinical endocrinology and metabolism.
[20] Efsa Panel on Dietetic Products. Scientific Opinion on Dietary Reference Values for vitamin A , 2015 .
[21] G. Carmeliet,et al. Maternal hypervitaminosis D reduces fetal bone mass and mineral acquisition and leads to neonatal lethality. , 2013, Bone.
[22] D. Reid,et al. Hip bone loss is attenuated with 1000 IU but not 400 IU daily vitamin D3: A 1‐year double‐blind RCT in postmenopausal women , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[23] D. Riccardi,et al. The extracellular calcium-sensing receptor, CaSR, in fetal development. , 2013, Best practice & research. Clinical endocrinology & metabolism.
[24] L. Rejnmark,et al. Changes in calcitropic hormones, bone markers and insulin-like growth factor I (IGF-I) during pregnancy and postpartum: a controlled cohort study , 2013, Osteoporosis International.
[25] C. Sempos,et al. Vitamin D status as an international issue: National surveys and the problem of standardization , 2012, Scandinavian journal of clinical and laboratory investigation. Supplementum.
[26] C. Cooper,et al. MAVIDOS Maternal Vitamin D Osteoporosis Study: study protocol for a randomized controlled trial. The MAVIDOS Study Group , 2012, Trials.
[27] L. Rejnmark,et al. Changes in bone mineral density and body composition during pregnancy and postpartum. A controlled cohort study , 2012, Osteoporosis International.
[28] U. Ozekıcı,et al. Bone turnover and maternal 25(OH) vitamin D3 levels during pregnancy and the postpartum period: should routine vitamin D supplementation be increased in pregnant women? , 2011, European journal of obstetrics, gynecology, and reproductive biology.
[29] JoAnn E. Manson,et al. The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know , 2010, The Journal of clinical endocrinology and metabolism.
[30] G. Karsenty,et al. Parathyroid hormone regulates fetal‐placental mineral homeostasis , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[31] Mikel Aickin,et al. Dealing with change: using the conditional change model for clinical research. , 2009, The Permanente journal.
[32] C. Cooper,et al. Maternal and seasonal predictors of change in calcaneal quantitative ultrasound during pregnancy. , 2005, The Journal of clinical endocrinology and metabolism.
[33] N. Lawson,et al. Changes in serum markers of bone turnover during normal pregnancy , 2003, Annals of clinical biochemistry.
[34] A. Paoletti,et al. Pattern of Bone Markers during Pregnancy and Their Changes after Delivery , 2003, Hormone Research in Paediatrics.
[35] C. Christiansen,et al. Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting. , 2002, Bone.
[36] C. Kovacs. Calcium and bone metabolism in pregnancy and lactation. , 2001, The Journal of clinical endocrinology and metabolism.
[37] W. Fraser,et al. A Detailed Assessment of Alterations in Bone Turnover, Calcium Homeostasis, and Bone Density in Normal Pregnancy , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[38] R. Eastell,et al. The Effect of Pregnancy on Bone Density and Bone Turnover , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[39] R. Heaney,et al. Vitamin D: How Much Do We Need, and How Much is Too Much? , 2000, Osteoporosis International.
[40] J. King,et al. A longitudinal study of calcium homeostasis during human pregnancy and lactation and after resumption of menses. , 1998, The American journal of clinical nutrition.
[41] B. Lanske,et al. Parathyroid hormone-related peptide (PTHrP) regulates fetal-placental calcium transport through a receptor distinct from the PTH/PTHrP receptor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[42] P. Delmas,et al. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[43] H. Minaguchi,et al. Changes in bone mass as determined by ultrasound and biochemical markers of bone turnover during pregnancy and puerperium: a longitudinal study. , 1996, The Journal of clinical endocrinology and metabolism.
[44] S. Robins. Collagen crosslinks in metabolic bone disease. , 1995, Acta orthopaedica Scandinavica. Supplementum.
[45] G. F. Krause,et al. Calcium homeostasis and bone metabolism during pregnancy, lactation, and postweaning: a longitudinal study. , 1995, The American journal of clinical nutrition.
[46] W. Fraser,et al. Changes in calciotrophic hormones and biochemical markers of bone turnover in normal human pregnancy. , 1994, European journal of endocrinology.
[47] D. Goltzman,et al. Does the maternal kidney contribute to the increased circulating 1,25-dihydroxyvitamin D concentrations during pregnancy? , 1988, Mineral and electrolyte metabolism.
[48] R. Kumar,et al. Elevated 1,25-dihydroxyvitamin D plasma levels in normal human pregnancy and lactation. , 1979, The Journal of clinical investigation.
[49] I. G. Macy,et al. THE CHEMICAL COMPOSITION OF THE HUMAN FETUS , 1933 .